Changes of Dose Delivery Distribution within the First Month after Permanent Interstitial Brachytherapy for Prostate Cancer

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Strahlentherapie und Onkologie (Print)

• Publication date

  2006-09-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/s00066-006-1529-5PMID 16944374
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interobserver Delineation Variation Using CT versus Combined CT + MRI in Intensity–Modulated Radiotherapy for Prostate Cancer

  2005cited by this paper
• Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy.

  2005cited by this paper
• Prostate cancer in a large prostate is associated with a decreased prostate specific antigen failure rate after brachytherapy.

  2005cited by this paper
• Epididymitis after prostate brachytherapy.

  2004cited by this paper
• 3-D Conformal HDR Brachytherapy as Monotherapy for Localized Prostate Cancer

  2004cited by this paper
• Evaluation of Dose-Volume Histograms after Prostate Seed Implantation

  2004cited by this paper
• Impact of Intraoperative Edema During Transperineal Permanent Prostate Brachytherapy on Computer-Optimized and Preimplant Planning Techniques

  2003cited by this paper
• Inverse Automated Treatment Planning with and without Individual Optimization in Interstitial Permanent Prostate Brachytherapy with High- and Low-Activity 125I

  2003cited by this paper
• Probability of late rectal morbidity in 125I prostate brachytherapy.

  2003cited by this paper
• Effect of prostatic edema on CT-based postimplant dosimetry.

  2002cited by this paper
• Physikalische Grundlagen und klinische Durchführung der interstitiellen Brachytherapie der Prostata mit Jod-125

  2002cited by this paper
• Impact of postimplant edema on V(100) and D(90) in prostate brachytherapy: can implant quality be predicted on day 0?

  2002cited by this paper
• [Physical basics and clinical realization of interstitial brachytherapy of the prostate with iodine 125].

  2002cited by this paper
• Dosimetric and radiographic correlates to prostate brachytherapy‐related rectal complications

  2001influential reference
• Determination of the urethral dose in prostate brachytherapy when the urethra cannot be visualized in the postimplant CT scan.

  2000cited by this paper
• ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer.

  2000cited by this paper
• The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis.

  2000cited by this paper
• Dosimetric effects of edema in permanent prostate seed implants: a rigorous solution.

  2000cited by this paper
• Comparability of CT-based and TRUS-based prostate volumes.

  1999cited by this paper
• American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer.

  1999cited by this paper
• A dynamic model for the estimation of optimum timing of computed tomography scan for dose evaluation of 125I or 103Pd seed implant of prostate.

  1999cited by this paper
• Optimum timing for image-based dose evaluation of 125I and 103PD prostate seed implants.

  1999cited by this paper
• Effect of post-implant edema on the rectal dose in prostate brachytherapy.

  1999cited by this paper
• Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy.

  1998cited by this paper
• Effect of edema on the post-implant dosimetry of an I-125 prostate implant: a case study.

  1997cited by this paper
• Impact of differences in ultrasound and computed tomography volumes on treatment planning of permanent prostate implants.

  1997cited by this paper
• Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy.

  1995cited by this paper

• A commentary on 125I seed brachytherapy for refractory loco-regional recurrence of non-anaplastic thyroid cancer

  2022cites this paper
• Permanent interstitial brachytherapy for prostate cancer implementing neoadjuvant prostatic artery embolization.

  2022cites this paper
• Spinocerebellar ataxia type 19/22 mutations alter heterocomplex Kv4.3 channel function and gating in a dominant manner

  2015cites this paper
• Repression of somatic cell fate in the germline

  2015cites this paper
• Protein O-mannosylation is crucial for human mesencyhmal stem cells fate

  2015cites this paper
• Mechanisms of gene targeting in higher eukaryotes

  2015cites this paper
• Loose versus stranded seeds in permanent prostate brachytherapy: dosimetric comparison of intraoperative plans.

  2014cites this paper
• Gold marker displacement due to needle insertion during HDR-brachytherapy for treatment of prostate cancer: A prospective cone beam computed tomography and kilovoltage on-board imaging (kV-OBI) study

  2012cites this paper
• Impact of learning curve and technical changes on dosimetry in low-dose brachytherapy for prostate cancer

  2012cites this paper
• Urinary morbidity after permanent prostate brachytherapy - impact of dose to the urethra vs. sources placed in close vicinity to the urethra.

  2012cites this paper
• Case series analysis of post-brachytherapy prostate edema and its relevance to post-implant dosimetry. Post-implant prostate edema and dosimetry

  2012cites this paper
• Greater postimplant swelling in small-volume prostate glands: implications for dosimetry, treatment planning, and operating room technique.

  2012cites this paper
• Displacement of periurethral stranded seeds and its dosimetric consequences in prostate brachytherapy.

  2011cites this paper
• Rectal morbidity after permanent interstitial brachytherapy for prostate cancer--impact of day 1 vs. day 30 computed tomography-based postimplant dosimetry.

  2010cites this paper
• Radiation Protection of Persons Living Close to Patients with Radioactive Implants

  2010cites this paper
• Preimplant factors affecting postimplant CT-determined prostate volume and the CT/TRUS volume ratio after transperineal interstitial prostate brachytherapy with 125I free seeds

  2010cites this paper
• Neoadjuvant hormonal therapy and external-beam radiotherapy versus external-beam irradiation alone for prostate cancer

  2009cites this paper
• Erectile dysfunction after external beam radiotherapy for prostate cancer.

  2009cites this paper
• Use of Gold Markers for Setup in Image-Guided Fractionated High-Dose-Rate Brachytherapy as a Monotherapy for Prostate Cancer

  2009cites this paper
• Rectal dosimetry following prostate brachytherapy with stranded seeds--comparison of transrectal ultrasound intra-operative planning (day 0) and computed tomography-postplanning (day 1 vs. day 30) with special focus on sources placed close to the rectal wall.

  2009cites this paper
• Time course of prostatic edema post permanent seed implant determined by magnetic resonance imaging.

  2009cites this paper
• Health-related quality of life after permanent I-125 brachytherapy and conformal external beam radiotherapy for prostate cancer--a matched-pair comparison.

  2009cites this paper
• The impact of prostate volume changes during external-beam irradiation in consequence of HDR brachytherapy in prostate cancer treatment

  2009cites this paper
• Critical discussion of different dose-volume parameters for rectum and urethra in prostate brachytherapy.

  2009cites this paper
• Toxicity profile with a large prostate volume after external beam radiotherapy for localized prostate cancer.

  2008cites this paper
• Long-Term Health-Related Quality-of-Life Outcomes after Permanent Prostate Brachytherapy

  2008cites this paper
• Seed Displacements after Permanent Brachytherapy for Prostate Cancer in Dependence on the Prostate Level

  2008influential citation
• Urethral Dose and Increment of International Prostate Symptom Score (IPSS) in Transperineal Permanent Interstitial Implant (TPI) of Prostate Cancer

  2008cites this paper
• Evaluation of source displacement and dose--volume changes after permanent prostate brachytherapy with stranded seeds.

  2007cites this paper
• Health-Related Quality of Life after Permanent Interstitial Brachytherapy for Prostate Cancer

  2006influential citation